X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Orchid Chemicals with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs TEVA PHARMA (Israel) - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   TEVA PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
TEVA PHARMA
Dec-13
ORCHID PHARMA LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1942,873-   
Low Rs352,496-   
Sales per share (Unadj.) Rs276.51,648.8-  
Earnings per share (Unadj.) Rs-79.2103.0-  
Cash flow per share (Unadj.) Rs-43.5236.3-  
Dividends per share (Unadj.) Rs090.17-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs53.91,831.5-  
Shares outstanding (eoy) m70.45848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.6 25.4%   
Avg P/E ratio x-1.426.1 -5.5%  
P/CF ratio (eoy) x-2.611.4 -23.2%  
Price / Book Value ratio x2.11.5 144.8%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m8,0672,276,346 0.4%   
No. of employees `0002.844.9 6.2%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.131,109.4 22.4%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.01,943.4 -102.6%   
INCOME DATA
Net Sales Rs m19,4771,398,213 1.4%  
Other income Rs m4070-   
Total revenues Rs m19,8841,398,213 1.4%   
Gross profit Rs m1,103382,901 0.3%  
Depreciation Rs m2,519113,019 2.2%   
Interest Rs m5,22727,463 19.0%   
Profit before tax Rs m-6,236242,419 -2.6%   
Minority Interest Rs m201,101 1.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511-159,135 -0.3%   
Tax Rs m-125-2,960 4.2%   
Profit after tax Rs m-5,58087,345 -6.4%  
Gross profit margin %5.727.4 20.7%  
Effective tax rate %2.0-1.2 -164.4%   
Net profit margin %-28.76.2 -458.6%  
BALANCE SHEET DATA
Current assets Rs m11,014944,348 1.2%   
Current liabilities Rs m32,060823,551 3.9%   
Net working cap to sales %-108.18.6 -1,250.7%  
Current ratio x0.31.1 30.0%  
Inventory Days Days9591 104.5%  
Debtors Days Days3496 35.0%  
Net fixed assets Rs m29,440456,687 6.4%   
Share capital Rs m7053,442 20.5%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8001,553,149 0.2%   
Long term debt Rs m9,018714,937 1.3%   
Total assets Rs m46,5103,195,364 1.5%  
Interest coverage x-0.29.8 -2.0%   
Debt to equity ratio x2.40.5 515.6%  
Sales to assets ratio x0.40.4 95.7%   
Return on assets %-0.83.6 -21.2%  
Return on equity %-146.95.6 -2,611.3%  
Return on capital %-3.74.9 -75.7%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682222,803 0.8%  
From Investments Rs m-9,860-78,948 12.5%  
From Financial Activity Rs m6,644-267,267 -2.5%  
Net Cashflow Rs m-1,535-123,412 1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.83 Rs / USD

Compare ORCHID PHARMA LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ORCHID PHARMA LTD With: ABBOTT INDIA  FDC LTD.  BIOCON   IPCA LABS  PFIZER  



Today's Market

Sensex Trades Flat; IT Stocks Under Pressure(12:30 pm)

Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the IT sector and FMCG sector witnessing selling pressure while realty stocks.

Related Views On News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Mar 26, 2019 12:23 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS